Commodore Capital Lp - Aug 7, 2023 Form 3 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
10%+ Owner
Signature
/s/ Michael Kramarz, Managing Partner
Stock symbol
VTGN
Transactions as of
Aug 7, 2023
Transactions value $
$0
Form type
3
Date filed
8/9/2023, 04:05 PM
Previous filing
Jun 22, 2023
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VTGN Common Stock 799K Aug 7, 2023 By Commodore Capital Master LP F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Dr. Kramarz and Dr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Dr. Kramarz and Dr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.